British American Tobacco rating upgraded by Fitch on strong cash flow

Fitch upgraded British American Tobacco’s long-term issuer default rating to A- from BBB+ with a Stable outlook. Fitch projects annual post-dividend free cash flow of GBP1.8–2.4bn for 2026–2028, expects EBITDA margin to rise to 48% by 2028 (from 47% in 2025), and notes next-generation products made an operating contribution of GBP442m in 2025 (up ~80% y/y). Fitch reported adjusted net leverage of 2.6x in 2025, forecasts 2.5x end-2026 and 2.3x end-2027, and highlighted GBP1.3bn buybacks for 2026 with potential GBP3.2bn assumed for 2027–28.

Analysis

Fitch’s move (and the market’s reaction) effectively lowers BAT’s marginal cost of capital and expands optionality for capital allocation; that dynamic usually translates into accelerated buybacks and opportunistic M&A or faster debt paydown, which can drive a 0.5–1.0x multiple re-rating over 6–18 months if execution stays conservative. That mechanical improvement in funding economics also compresses credit spreads and increases the attractiveness of carry trades in sterling-denominated paper, creating a window to harvest spread compression before it fully flows into equity multiples.

The competitive map shifts subtly: companies with diversified geographic footprints and multi-category portfolios are better insulated from localized regulatory shocks, so BAT’s global scale should amplify the upgrade’s benefits relative to US‑centric peers. Meanwhile, the upstream suppliers and packaging/automation vendors that serve next-generation product lines will see steadier order books and pricing power — a classic second-order beneficiary group often overlooked by equity buyers focused solely on cigarette volume trends.

Key reversals to watch are enforcement and illicit-market dynamics, which can swing legal-channel volumes within a single quarter, and macro moves (rate spikes or EM FX shocks) that re-accelerate leverage ratios despite improved funding. Market-implied credit moves and debt-maturity walls are the highest-probability near-term catalysts; set alerts for significant CDS spread moves, cross-currency funding spreads, and any major regulatory announcements over the next 3–12 months.

Key Decisions for Investors

• Long BTI equity (size 1–2% NAV): buy into weakness with a 6–12 month horizon. Target 20–30% upside on a 0.5–1.0x multiple rerate plus continued buybacks; stop-loss at -12% to control political/regulatory gamma.
• Pair trade — Long BTI / Short MO (equal notional, 6–12 months): exploit credit/portfolio diversification differential. Expect relative outperformance of 10–20% if credit spreads compress and buybacks persist; downside is regulatory shock to next‑gen products that hits both legs.
• Credit trade — buy BTI 5y senior bonds (or receive protection via CDS if liquidity allows), horizon 6–12 months: target 25–50bps spread tightening. Position size modest (0.5–1% NAV) due to tail risk from sudden regulatory/legal news.
• Volatility-efficient option play — buy 12‑month BTI call spread (long nearer-term call, sell higher strike same expiry) sized to limit premium, horizon 9–12 months: asymmetric payoff if multiple expansion occurs while capping premium lost if adverse news arrives.